from web site
View abstract. Collin, C., Davies, P., Mutiboko, I. K., and Ratcliffe, S. Randomized controlled trial of cannabis-based medication in spasticity triggered by numerous sclerosis. Eur. J.Neurol. 2007; 14( 3 ):290 -296. View abstract. Collin, C., Ehler, E., Waberzinek, G., Alsindi, Z., Davies, P., Powell, K., Notcutt, W., O'Leary, C., Ratcliffe, S., Novakova, I., Zapletalova, O., Pikova, J., and Ambler, Z.
Neurol. Res. 2010; 32( 5 ):451 -459. View abstract. Consroe, P., Kennedy, K., and Schram, K. Assay of plasma cannabidiol by capillary gas chromatography/ion trap mass spectroscopy following high-dose duplicated daily oral administration in humans. Pharmacol Biochem. Behav. 1991; 40( 3 ):517 -522. View abstract. Consroe, P., Laguna, J., Allender, J., Snider, S., Stern, L., Sandyk, R., Kennedy, K., and Schram, K.
Pharmacol Biochem. Behav. 1991; 40( 3 ):701 -708. View abstract. Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R., Sanvito, W. L., Lander, N., and Mechoulam, R. Chronic administration of cannabidiol to healthy volunteers and epileptic clients. Pharmacology 1980; 21( 3 ):175 -185. View abstract. Harvey, D. J., Samara, E., and Mechoulam, R.
Pharmacol Biochem. Behav. 1991; 40( 3 ):523 -532. View abstract. Iuvone, T., Esposito, G., Esposito, R., Santamaria, R., Di Rosa, M., and Izzo, A. A. Neuroprotective effect of cannabidiol, a non-psychoactive part from Marijuana sativa, on beta-amyloid-induced toxicity in PC12 cells. J Neurochem. 2004; 89( 1 ):134 -141. View abstract. Ohlsson, A., Lindgren, J. E., Andersson, S., Agurell, S., Gillespie, H., and Hollister, L.
Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration. Biomed. Environ Mass Spectrom. 1986; 13( 2 ):77 -83. View abstract. Srivastava, M. D., Srivastava, B. I., and Brouhard, B. Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. Immunopharmacology 1998; 40( 3 ):179 -185. View abstract. Trembly B, Sherman M. Double-blind scientific research study of cannabidiol as a secondary anticonvulsant.
Wade, D. T., Collin, C., Stott, C., and Duncombe, P. Meta-analysis of the effectiveness and security of Sativex (nabiximols), on spasticity in people with numerous sclerosis. Mult. Scler. 2010; 16( 6 ):707 -714. Learn More Here . Wade, D. T., Makela, P., Robson, P., House, H., and Bateman, C. Do cannabis-based medical extracts have general or specific results on signs in numerous sclerosis? A double-blind, randomized, placebo-controlled research study on 160 clients.